References
- Cox, D.R. (1972). Regression Models and Life-Tables. Journal of the Royal Statistical Society, Series B 34(2):187–220.
- Howe, J.C., Cole, J.S., Chmiel, J.S., and Munoz, A. (2011). Limitation of Inverse Probability-of-Censoring Weights in Estimating Survival in the Presence of Strong Selection Bias. Practice of Epidemiology 173(5):569–577.
- Johnson & Johnson Pharmaceutical Research & Development Clinical study Report, EDMS-USRA-7548071:3.0. (2002) A Randomized, Double-Blind, Parallel Group, Monotherapy Study to Compare the Safety and Efficacy of Two Doses of Topiramate in the Treatment of Newly Diagnosed or Recurrent Epilepsy.
- Mantel, N. (1966). Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports 50(3):163–70.
- Robins, J.M., Finkelstein, D.M. (2000). Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics 56(3):779–788.
- Peto, R. and Peto, J. (1972). Asymptotically Efficient Rank Invariant Test Procedures. Journal of the Royal Statistical Society, Series A 135(2):185–207.
- Glauser, T.A., Dlugos, D.J., Dodson, W.E., Grinspan, A., Wang, S., Wu, S.C. (2007). Topiramate Monotherapy in Newly Diagnosed Epilepsy in Children and Adolscents. Journal of Child Neurology 22(6):693–699.